Please login to the form below

Not currently logged in
Email:
Password:

Boyds

This page shows the latest Boyds news and features for those working in and with pharma, biotech and healthcare.

R&D news in brief

Eckland joins Ark Therapeutics from Takeda Europe and replaces Alan Boyd who has decided to move into a part-time role within the company.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Envigo appoints Lizanne Muller as president, EMEA operations Envigo appoints Lizanne Muller as president, EMEA operations

    And Craig Boyd joins from Mayne Pharma as chief commercial officer. ... Envigo has also appointed Craig Boyd as chief commercial officer.

  • Boyds expands regulatory affairs team Boyds expands regulatory affairs team

    Céline Courtay-Cahen joins the pharma and biotech consultancy. Boyd Consultants has appointed Céline Courtay-Cahen as a regulatory affairs consultant, based out of its Cambridge, UK office. ... Alan Boyd, founder and chief executive officer of Boyd

  • Caldan Therapeutics bolsters senior team Caldan Therapeutics bolsters senior team

    Dr Frank Armstrong, Dr Philip Boyd, Dr Gerry Thomas and Dr Stephen Connolly join. ... Also joining Caldan Therapeutics are Dr Philip Boyd and Dr Stephen Connolly, who become chief financial officer and vice president of drug discovery, respectively.

  • Boyds appoints Dr Nick Meyers and Natasha Nesterova-Smith Boyds appoints Dr Nick Meyers and Natasha Nesterova-Smith

    Dr Meyers joined Boyds in January, having most recently held senior management positions with Daiichi Sankyo Development, CRO and PPD. ... Meanwhile, Nesterova-Smith joined Boyds in December 2015 bringing experience as a regulatory professional at Amgen,

  • Roche's Julie Warner joins Boyds Roche's Julie Warner joins Boyds

    UK-based drug development consultancy Boyds has appointed Julie Warner as associate director within its regulatory affairs team. ... Alan Boyd, CEO and founder of Boyds, said: “Dr Warner's appointment is excellent news for Boyds.

More from appointments
Approximately 3 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics